LINC01810

Across TCGA pan-cancer cohorts, LINC01810 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC01810 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01810 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01810 expression acts as an unfavorable survival marker.

HNSC, BLCA, and SKCM are the cancer types where LINC01810 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.082	0.711	<.001	135	view →
BLCA	DFS	Tertile	All	0.146	0.627	<.001	72	view →
SKCM	DFS	Tertile	All	0.079	0.739	<.001	54	view →
MESO	DFS	Tertile	III,IV	0.043	0.415	<.001	54	view →
OV	OS	Tertile	IV	0.028	0.759	.002	36	view →
COAD	OS	Tertile	III,IV	0.163	0.791	.004	36	view →
STAD	DFS	Tertile	All	0.301	0.722	.004	27	view →
UCEC	OS	Tertile	All	0.796	0.928	.029	18	view →
BRCA	OS	Tertile	All	0.191	0.579	.011	12	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC01810–HNSC (OS)

Open the HNSC breakdown →